Td Waterhouse Canada Inc. Protalix Bio Therapeutics, Inc. Call Options Transaction History
Td Waterhouse Canada Inc.
- $12.4 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
49Shares Held
4.31MCall Options Held
61.1KPut Options Held
23.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.12MShares$3.01 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL732KShares$1.97 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny388KShares$1.04 Million0.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$896,2290.0% of portfolio
-
Gsa Capital Partners LLP London, X0306KShares$822,4640.04% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $134M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...